Results 61 to 70 of about 32,698 (277)
American Journal of Hematology, EarlyView.ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez +17 more
wiley +1 more source
Late-Relapsing Hepatitis after Yellow Fever
Viruses, 2020 One patient presented hyporexia, asthenia, adynamia, and jaundice two months after acute yellow fever (YF) onset; plus laboratory tests indicating hepatic cytolysis and a rebound of alanine and aspartate transaminases, and total and direct bilirubin ...
Izabela Maurício Rezende +18 more
doaj +1 more source
Comparative Analysis of Tick-Borne Relapsing Fever Spirochaetes from Ethiopia and Nigeria [PDF]
In recent decades, the reports of tick-borne relapsing fever (TBRF) spirochaetes and its tick vectors have been increasing in Africa. Soft ticks of the Ornithodoros genus are the predominant vector for these spirochaetes and are endemic in many regions ...
Bankole, Adefolake
core +1 more source
American Journal of Hematology, EarlyView.ABSTRACT The predictive value of cytokines (CK) for malignancy‐associated adult hemophagocytic lymphohistiocytosis (M‐HLHa) remains uncertain. We evaluated a cytokine‐based Risk Score (RS) and the IL‐10/IL‐6 Ratio to predict M‐HLHa. Adult patients (n = 112) from the French HLH cohort (NCT02113917) with complete data for nine key HLH related CK measured
Coralie Bloch +47 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.
Chiara Veredice +4 more
wiley +1 more source
American Journal of Hematology, EarlyView.ABSTRACT Quizartinib is a tyrosine kinase inhibitor with single agent activity in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) and has demonstrated efficacy in first‐line therapy when combined with intensive chemotherapy in both FLT3 ITD‐negative and positive AML.
Teresa Bernal +29 more
wiley +1 more source
Forgotten diseases: relapsing fever
, 2004 Relapsing fever is a group of conditions that is characterized by recurrent febrile episodes interspaced with periods of no symptoms at all. They are arthropod-borne spirochetal infections of the Borrellia genus and occur in two main forms: tick-borne ...
Gangaidzo, I.T.
core +1 more source
Be aware of tick-borne relapsing fever [PDF]
Tick-borne relapsing fever (TBRF) is a rare infection linked to sleeping in rustic cabins, particularly cabins in mountainous areas of the western United States. The main symptoms of TBRF are high fever (e.g., 103\ub0 F), headache, muscle and joint aches.
core
American Journal of Hematology, EarlyView.ABSTRACT Dordaviprone is a first‐in‐class small‐molecule imipridone. In preclinical studies, it is active against leukemia cells harboring a TP53 mutation or complex karyotype and leukemia stem cells while sparing normal bone marrow cells. This study aimed to determine the safety of dordaviprone maintenance after allogeneic hematopoietic cell ...
Vijaya Raj Bhatt +8 more
wiley +1 more source